Showing results (341-350 of 386) with videos related to

Sort By:
Pageof 39
Pediatric Blood & Cancer|October 21, 2014
Pubertal development and primary ovarian insufficiency in female survivors of embryonal brain tumors following risk-adapted craniospinal irradiation and adjuvant chemotherapyMariko DeWire, Daniel M Green, Charles A Sklar, et al.
Neuro-Oncology|February 23, 2011
Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomasDaphne A Haas-Kogan, Anuradha Banerjee, Tina Young Poussaint, et al.
International Journal of Radiation Oncology, Biology, Physics|July 24, 2009
Preliminary results from a prospective study using limited margin radiotherapy in pediatric and young adult patients with high-grade nonrhabdomyosarcoma soft-tissue sarcomaMatthew J Krasin, Andrew M Davidoff, Xiaoping Xiong, et al.
Neuro-Oncology|November 15, 2014
Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapyKaren Tsui, Amar Gajjar, Chenghong Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 15, 2011
Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor ConsortiumKatherine A Zukotynski, Frederic H Fahey, Mehmet Kocak, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2010
A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomasJ Russell Geyer, Clinton F Stewart, Mehmet Kocak, et al.
Journal of Pediatric Hematology/Oncology|November 5, 1997
A phase II trial of high-dose methotrexate in previously untreated children and adolescents with high-risk unresectable or metastatic rhabdomyosarcomaA S Pappo, L C Bowman, W L Furman, et al.
Pediatric Blood & Cancer|December 10, 2008
Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumorsMark W Kieran, Jeffrey G Supko, Dana Wallace, et al.
Frontiers in Oncology|April 19, 2014
Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade GliomasIbrahim Qaddoumi, Mehmet Kocak, Atmaram S Pai Panandiker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Induction chemotherapy and conformal radiation therapy for very young children with nonmetastatic medulloblastoma: Children's Oncology Group study P9934David M Ashley, Thomas E Merchant, Douglas Strother, et al.
Pageof 39